This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks to Watch: Sanmina, Novartis

NEW YORK ( TheStreet) -- Electronics manufacturing company Sanmina-SCI (SANM) dropped 17.6% to $11.04 in premarket trading Thursday after cutting its second-quarter earnings forecast to between 28 cents and 32 cents a share, compared with analysts' forecasts of 41 cents a share and the company's previous forecast of 40 cents to 43 cents.

The company said a delay in defense market projects and shipments due to federal budget uncertainty, a recently resolved labor strike in India delaying certain product shipments and short-term softness in the optical market hurt its forecast. Sanmina said that its Chief Operating Officer Hari Pillai is stepping down, but will continue to serve as a consultant.

Novartis (NVS) was rising 1.5% to $53.54 after the New England Journal of Medicine reported that the Xolair asthma drug the drug maker and its peer Roche ( RHHBY ) sells helped cut symptoms in young adults and children.

Financial institutions Bank of America (BAC), Citigroup (C) and UBS (UBS) are all part of a U.S. investigation of the possible manipulation of the London Interbank Offered Rate, The Wall Street Journal reported. Citigroup was up 0.5% to $4.41, Bank of America was up 0.9% to $13.81 and UBS was rising 1% to $18.10 in premarket trading.

Drug developer Abbott Labs (ABT) was rising 0.6% to $47 after DepoMed (DEPO) said in a regulatory filing that it has reached a settlement agreement with the former with regard to Gralise, a once-daily treatment for postherpetic neuralgia. DepoMed was 0.4% higher at $8.71.

Athletic apparel retailer Lululemon Athletica (LULU) was flat at $79.42 after reporting fourth-quarter earnings of 76 cents a share including a tax adjustment, and earnings of 64 cents a share on an adjusted basis, beating expectations of 57 cents a share.

Specialty retailer Guess? (GES) posted an in-line adjusted profit for its fiscal fourth quarter but gave a below-consensus outlook.

>>Search for Highest Dividends by Rate or Yield

More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to:

Copyright 2010 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AAPL $124.25 -0.14%
FB $81.66 -0.67%
GOOG $542.56 -0.99%
TSLA $187.59 -0.63%
YHOO $44.13 -0.69%


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs